Veterinary Stereotactic Radiosurgery System Market to Grow with a CAGR of 10.22% through 2030
The
rise in pet ownership and the increasing awareness of advanced treatment
options for pets with cancer, is expected to drive the Global Veterinary
Stereotactic Radiosurgery System Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Veterinary Stereotactic Radiosurgery System Market
– Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Veterinary Stereotactic Radiosurgery
System Market stood at USD 3.46
Billion in 2024 and is expected to reach USD 6.21 Billion by
2030 with a CAGR of 10.22% during the forecast period. The Global Veterinary Stereotactic
Radiosurgery (VSRS) System Market is witnessing rapid growth due to the
continuous evolution in veterinary oncology treatments. With advancements in
medical technologies, the veterinary sector now has access to more accurate and
effective therapies for treating cancers in animals, particularly in pets like
dogs and cats. Stereotactic radiosurgery, known for its precision, offers a
non-invasive alternative to traditional treatments such as surgery, making it
increasingly popular among veterinary professionals and pet owners. This trend
is reinforced by the growing recognition of the benefits of radiosurgery, such
as quicker recovery times and fewer side effects, which make it an attractive
option for treating various types of tumors in pets.
A
key factor driving market growth is the rise in the number of veterinary
oncology specialists who are adopting cutting-edge technology in their
practice. These experts are enabling better clinical outcomes by offering
advanced treatment modalities such as stereotactic radiosurgery. Pet owners are
also becoming more informed and seeking out these high-quality treatments for
their pets, leading to increased demand for such technologies. The market is
further boosted by growing partnerships between veterinary clinics and medical
equipment manufacturers, which are facilitating the availability of high-end
radiosurgery systems to a wider range of veterinary facilities. These
collaborations are helping make veterinary stereotactic radiosurgery more
accessible, providing significant growth opportunities for the market.
The
market presents multiple growth opportunities, particularly with the expansion
of veterinary care into emerging markets. As pet ownership continues to rise in
developing regions, there is a growing demand for advanced treatment options
that can improve animal health outcomes. Additionally, continuous advancements
in imaging and radiation technologies offer the opportunity to create more
efficient and effective veterinary radiosurgery systems that are both
affordable and accessible. With more veterinary hospitals and clinics offering
oncology services, and with increasing pet healthcare expenditure, there is
substantial room for the market to grow in untapped regions. The focus on
personalized pet care, which includes specialized treatments like stereotactic
radiosurgery, also presents an opportunity for market expansion in the coming
years.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Veterinary Stereotactic Radiosurgery System Market”
The Global Veterinary
Stereotactic Radiosurgery System Market is segmented into product, application,
end user, regional distribution, and company.
Based on the Application,
Brain Tumours emerged as the fastest growing segment in the Global Veterinary
Stereotactic Radiosurgery System Market during the forecast period. This can be
attributed to the increasing prevalence of brain tumors in pets, particularly
in dogs and cats. Brain tumors are often difficult to treat through
conventional surgical methods due to the sensitive location and the potential
risks associated with invasive procedures. As a result, SRS has become a
preferred non-invasive treatment option for these tumors, offering precise
targeting of the tumor while minimizing damage to surrounding healthy tissue. The
growing awareness among pet owners about advanced treatments for brain tumors
and the rising demand for specialized veterinary care have contributed to the
rapid adoption of SRS for brain tumor treatment. Furthermore, advancements in
imaging technologies and treatment planning software have improved the
precision and efficacy of SRS, making it a highly attractive option for
veterinarians dealing with brain tumor cases in animals.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Veterinary Stereotactic Radiosurgery System Market during the forecast period. The
Asia-Pacific region is seeing an expansion of veterinary oncology practices,
with more veterinary hospitals and specialty clinics adopting cutting-edge
technologies to provide cancer treatments. The region is gradually catching up
with Western markets in terms of veterinary oncology services, with countries
like Japan and Australia leading the way in adopting SRS for treating complex
conditions like brain tumors and other cancers. The increased availability of
advanced radiation therapy systems is opening new avenues for animal
healthcare, especially in regions that have historically lacked such
facilities. Additionally, the entry of multinational veterinary SRS system
manufacturers into the Asia-Pacific market has facilitated the growth of this
segment by providing more cost-effective and accessible options for veterinary
practices. This is expected to drive the rapid adoption of SRS systems across
the region during the forecast period.
Major
companies operating in Global Veterinary Stereotactic Radiosurgery System
Market are:
- Avante
Health Solutions
- Accuray
Inc.
- Elekta
AB
- Varian
Medical Systems Inc.
- PetCure
Oncology
- Xstrahl
Inc.
- CVS
Group
- Medtronic
PLC
- Nanovi
AS
- Merck
& Co. Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Veterinary Stereotactic
Radiosurgery System Market is expanding due to the increasing adoption of
advanced cancer treatment technologies in veterinary clinics, with a particular
focus on improving precision and reducing side effects for pets. The growing
awareness among pet owners regarding the availability of non-invasive, highly
effective treatment options for cancer, such as stereotactic radiosurgery, is
driving this trend. As more veterinary institutions invest in cutting-edge
technologies like linear accelerators and robotic platforms, the market is
poised for significant growth. This shift towards technologically advanced
solutions aligns with the broader trend of enhancing veterinary care with
state-of-the-art equipment. These developments are boosting the demand for
specialized stereotactic radiosurgery systems that offer high levels of
accuracy and minimal discomfort for animals, ensuring better outcomes.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Veterinary Stereotactic
Radiosurgery System Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, Segmented By Product (Gamma Knife, LINAC, Proton Beam Radiation
Therapy (PBRT)/ Flash-RT, CyberKnife), By Application (Brain Tumours, Spinal
Tumours, Other Applications), By End User (Veterinary Hospitals, Veterinary
Specialty Clinics, Research and Academic Institutions), By Region and
Competition, 2020-2030F”, has evaluated the future growth potential of Global
Veterinary Stereotactic Radiosurgery System Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Veterinary Stereotactic Radiosurgery System Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com